AccurKardia has been granted a U.S. patent for a machine learning-based system designed to identify cardiac amyloidosis from a standard 12-lead electrocardiogram, positioning the ECG analytics company ...

Clinicians often use a medical test called a 12-lead electrocardiogram (ECG) to diagnose heart problems. It uses electrodes ...

Department of Medical-Diagnostic Sciences, University of Padua, Padua, Italy Correspondence to Dr D Corrado, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, ...

Heart disease remains the leading cause of death worldwide, and although electrocardiography (ECG) is critical for diagnosis, interpreting ECG signals requires extensive training. Current machine ...

In a study of patients with cutaneous sarcoidosis, ECG abnormalities identified all cases of cardiac involvement, demonstrating 100% sensitivity and 100% negative predictive value. Researchers ...

Issuance of new reimbursement-related codes expected to accelerate the use and adoption of ECG-based cardiac dysfunction AI algorithms, including HeartSciences’ MyoVista SOUTHLAKE, Texas, Oct. 19, ...

Wearable biosensor Inventors Peter Elango and Madhu Bhaskaran holding the dry electrodes, part of the RMIT ECG device. (Courtesy: Seamus Daniel, RMIT University) Conventional electrocardiograms (ECG) ...

BELLEVUE, Wash.--(BUSINESS WIRE)--Cardiac Insight, Inc., a healthcare innovator specializing in wearable electrocardiogram (ECG) cardiac sensors and proven automated ECG analysis that delivers ...

AccurKardia's patent establishes its intellectual property foundation across all major amyloidosis subtypes, including AL amyloidosis and wild-type and hereditary ATTR amyloidosis. It joins a growing ...